Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Primary and Chronic HIV Infection Differently Modulates Mucosal Vδ1 and Vδ2 T-Cells Differentiation Profile and Effector Functions.

Cimini E, Agrati C, D'Offizi G, Vlassi C, Casetti R, Sacchi A, Lionetti R, Bordoni V, Tumino N, Scognamiglio P, Martini F.

PLoS One. 2015 Jun 18;10(6):e0129771. doi: 10.1371/journal.pone.0129771. eCollection 2015.

2.

Autophagy plays an important role in the containment of HIV-1 in nonprogressor-infected patients.

Nardacci R, Amendola A, Ciccosanti F, Corazzari M, Esposito V, Vlassi C, Taibi C, Fimia GM, Del Nonno F, Ippolito G, D'Offizi G, Piacentini M.

Autophagy. 2014 Jul;10(7):1167-78. doi: 10.4161/auto.28678. Epub 2014 Apr 29.

3.

Temporal trend and characteristics of recent HIV-1 infections: application of an algorithm for the identification of recently acquired HIV-1 infections among newly diagnosed individuals over a 10-year period.

Orchi N, Sias C, Vlassi C, Navarra A, Angeletti C, Puro V, Sciarrone MR, Capobianchi MR, Girardi E.

New Microbiol. 2013 Oct;36(4):353-61. Epub 2013 Oct 1.

4.

Quasispecies tropism and compartmentalization in gut and peripheral blood during early and chronic phases of HIV-1 infection: possible correlation with immune activation markers.

Rozera G, Abbate I, Vlassi C, Giombini E, Lionetti R, Selleri M, Zaccaro P, Bartolini B, Corpolongo A, D'Offizi G, Baiocchini A, Del Nonno F, Ippolito G, Capobianchi MR.

Clin Microbiol Infect. 2014 Mar;20(3):O157-66. doi: 10.1111/1469-0691.12367. Epub 2013 Oct 18.

5.

In vivo interferon-alpha/ribavirin treatment modulates Vγ9Vδ2 T-cell function during chronic HCV infection.

Cimini E, Bonnafous C, Sicard H, Vlassi C, D'Offizi G, Capobianchi MR, Martini F, Agrati C.

J Interferon Cytokine Res. 2013 Mar;33(3):136-41. doi: 10.1089/jir.2012.0050. Epub 2013 Jan 11.

PMID:
23308376
6.

Ultra-deep sequencing reveals hidden HIV-1 minority lineages and shifts of viral population between the main cellular reservoirs of the infection after therapy interruption.

Rozera G, Abbate I, Ciccozzi M, Lo Presti A, Bruselles A, Vlassi C, D'Offizi G, Narciso P, Giombini E, Bartolini B, Ippolito G, Capobianchi MR.

J Med Virol. 2012 Jun;84(6):839-44. doi: 10.1002/jmv.23292.

PMID:
22996031
7.

Interferon-α improves phosphoantigen-induced Vγ9Vδ2 T-cells interferon-γ production during chronic HCV infection.

Cimini E, Bonnafous C, Bordoni V, Lalle E, Sicard H, Sacchi A, Berno G, Gioia C, D'Offizi G, Visco Comandini U, Vlassi C, Capobianchi MR, Martini F, Agrati C.

PLoS One. 2012;7(5):e37014. doi: 10.1371/journal.pone.0037014. Epub 2012 May 22.

8.

Detection of quasispecies variants predicted to use CXCR4 by ultra-deep pyrosequencing during early HIV infection.

Abbate I, Vlassi C, Rozera G, Bruselles A, Bartolini B, Giombini E, Corpolongo A, D'Offizi G, Narciso P, Desideri A, Ippolito G, Capobianchi MR.

AIDS. 2011 Mar 13;25(5):611-7. doi: 10.1097/QAD.0b013e328343489e.

PMID:
21160417
9.

The basal activation state of DC subsets correlates with anti-HCV treatment outcome in HCV/HIV co-infected patients.

Sacchi A, Agrati C, D'Offizi G, Vlassi C, Rozera G, Abbate I, Capobianchi MR, Martini F.

Clin Immunol. 2011 Feb;138(2):178-86. doi: 10.1016/j.clim.2010.11.001. Epub 2010 Dec 3.

PMID:
21130688
10.

Hepatitis C virus production requires apolipoprotein A-I and affects its association with nascent low-density lipoproteins.

Mancone C, Steindler C, Santangelo L, Simonte G, Vlassi C, Longo MA, D'Offizi G, Di Giacomo C, Pucillo LP, Amicone L, Tripodi M, Alonzi T.

Gut. 2011 Mar;60(3):378-86. doi: 10.1136/gut.2010.211292. Epub 2010 Oct 12.

PMID:
20940285
11.

Co-stimulatory molecule CD80 expression may correlate with anti-HCV treatment outcome.

Sacchi A, Agrati C, D'Offizi G, Vlassi C, Martini F.

Gut. 2011 Aug;60(8):1161-2. doi: 10.1136/gut.2010.210765. Epub 2010 Aug 30. No abstract available.

PMID:
20805310
12.

Tolerability of HAART in patients treated during acute HIV infection.

Vlassi C, Corpolongo A, D'Offizi G, Scognamiglio P, Salvatori MF, Fezza R, Narciso P.

J Acquir Immune Defic Syndr. 2010 Aug;54(5):e11-2. doi: 10.1097/QAI.0b013e3181e3b266. No abstract available.

PMID:
20647820
13.

Archived HIV-1 minority variants detected by ultra-deep pyrosequencing in provirus may be fully replication competent.

Rozera G, Abbate I, Bruselles A, Vlassi C, D'Offizi G, Narciso P, Chillemi G, Prosperi M, Ippolito G, Capobianchi MR.

AIDS. 2009 Nov 27;23(18):2541-3. doi: 10.1097/QAD.0b013e32832fd2e1. No abstract available.

PMID:
19907212
14.

Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders.

Tozzi V, Balestra P, Salvatori MF, Vlassi C, Liuzzi G, Giancola ML, Giulianelli M, Narciso P, Antinori A.

J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):56-63. Erratum in: J Acquir Immune Defic Syndr. 2009 Dec 1;52(4):529.

PMID:
19731418
15.

Zoledronic acid and interleukin-2 treatment improves immunocompetence in HIV-infected persons by activating Vgamma9Vdelta2 T cells.

Poccia F, Gioia C, Martini F, Sacchi A, Piacentini P, Tempestilli M, Agrati C, Amendola A, Abdeddaim A, Vlassi C, Malkovsky M, D'Offizi G.

AIDS. 2009 Mar 13;23(5):555-65. doi: 10.1097/QAD.0b013e3283244619.

PMID:
19238075
16.

Massively parallel pyrosequencing highlights minority variants in the HIV-1 env quasispecies deriving from lymphomonocyte sub-populations.

Rozera G, Abbate I, Bruselles A, Vlassi C, D'Offizi G, Narciso P, Chillemi G, Prosperi M, Ippolito G, Capobianchi MR.

Retrovirology. 2009 Feb 12;6:15. doi: 10.1186/1742-4690-6-15.

17.

Ability of peripheral blood mononuclear cells to activate interferon response in vitro is predictive of virological response in HCV patients.

Lalle E, Calcaterra S, Horejsh D, Abbate I, D'Offizi G, Abdeddaim A, Vlassi C, Antonucci G, Capobianchi MR.

J Biol Regul Homeost Agents. 2008 Jul-Sep;22(3):153-60.

PMID:
18842168
18.

Interferon may prevent HIV viral rebound after HAART interruption in HIV patients.

Dianzani F, Rozera G, Abbate I, D'Offizi G, Abdeddaim A, Vlassi C, Antonucci G, Narciso P, Martini F, Capobianchi MR.

J Interferon Cytokine Res. 2008 Jan;28(1):1-3. doi: 10.1089/jir.2007.0076.

PMID:
18370866
19.

The 2005 Italian Quality Control Study for the evaluation of CD4 cells in centers involved in the treatment of HIV type 1 patients.

Martini F, D'Offizi G, Girardi E, Vitale A, Cimini E, Mollicone B, Vlassi C, Aiuti F; Other Members of 2005 Italian CD4 Quality Control Network.

AIDS Res Hum Retroviruses. 2007 Jun;23(6):777-81.

PMID:
17604540
20.

Virological characterization of patients treated early is able to control HIV-1 replication after multiple cycles of structured therapy interruption.

Rozera G, Abbate I, D'Offizi G, Corpolongo A, Narciso P, Vlassi C, Martini F, Calcaterra S, Capobianchi MR.

J Med Virol. 2007 Aug;79(8):1047-54.

PMID:
17597482
21.

Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors.

Tozzi V, Balestra P, Bellagamba R, Corpolongo A, Salvatori MF, Visco-Comandini U, Vlassi C, Giulianelli M, Galgani S, Antinori A, Narciso P.

J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):174-82.

PMID:
17356465
22.

Imported malaria at Italy's National Institute for Infectious Diseases Lazzaro Spallanzani, 1984-2003.

Spinazzola F, Nicastri E, Vlassi C, Ghirga P, De Marco M, Pittalis S, Paglia MG, Ferrari C, Narciso P.

Eur J Clin Microbiol Infect Dis. 2007 Mar;26(3):175-9.

PMID:
17318481
23.

Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART.

Tozzi V, Balestra P, Serraino D, Bellagamba R, Corpolongo A, Piselli P, Lorenzini P, Visco-Comandini U, Vlassi C, Quartuccio ME, Giulianelli M, Noto P, Galgani S, Ippolito G, Antinori A, Narciso P.

AIDS Res Hum Retroviruses. 2005 Aug;21(8):706-13.

PMID:
16131310
24.

Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort.

Tozzi V, Balestra P, Lorenzini P, Bellagamba R, Galgani S, Corpolongo A, Vlassi C, Larussa D, Zaccarelli M, Noto P, Visco-Comandini U, Giulianelli M, Ippolito G, Antinori A, Narciso P.

J Neurovirol. 2005 Jul;11(3):265-73.

PMID:
16036806

Supplemental Content

Loading ...
Support Center